 |
Viatris
VTRS
|
$ 13.83
|
16.6 B
|
$ 172 M
|
-4.7
|
1.1
|
$ -2.8
|
 |
 |
Tilray
TLRY
|
$ 6.72
|
4.15 B
|
$ -105 M
|
-0.6
|
5.0
|
$ -10.3
|
 |
 |
Bausch Health Companies
BHC
|
$ 5.72
|
2.09 B
|
$ 3.23 B
|
-5.1
|
0.2
|
$ -1.1
|
 |
 |
Perrigo Company plc
PRGO
|
$ 11.31
|
1.57 B
|
$ 579 M
|
-51.7
|
0.4
|
$ -0.2
|
 |
 |
Harrow Health
HROW
|
$ 37.1
|
1.36 B
|
$ 17.6 M
|
-79.8
|
5.7
|
$ -0.4
|
 |
 |
Cronos Group
CRON
|
$ 2.57
|
1.35 B
|
∙ |
∙ |
∙ |
∙ |
 |
 |
Pacira BioSciences
PCRX
|
$ 24.06
|
1.11 B
|
$ -75.6 M
|
-7.9
|
1.6
|
$ -3.0
|
 |
 |
Solid Biosciences
SLDB
|
$ 8.39
|
734 M
|
$ -115 M
|
-3.5
|
35.6
|
$ -2.3
|
 |
 |
Emergent BioSolutions
EBS
|
$ 8.24
|
422 M
|
$ -238 M
|
-1.1
|
0.4
|
$ -7.5
|
 |
 |
Veru
VERU
|
$ 2.38
|
321 M
|
$ -31.2 M
|
-1.7
|
23.6
|
$ -1.4
|
 |
 |
Organogenesis Holdings
ORGO
|
$ 2.38
|
313 M
|
$ 2.42 M
|
-34.0
|
0.7
|
$ -0.1
|
 |
 |
Relmada Therapeutics
RLMD
|
$ 7.38
|
291 M
|
$ -165 M
|
-3.8
|
-268.7
|
$ -1.9
|
 |
 |
Evolus
EOLS
|
$ 4.33
|
279 M
|
$ -48.4 M
|
-3.8
|
1.0
|
$ -1.1
|
 |
 |
Assertio Holdings
ASRT
|
$ 18.02
|
115 M
|
$ -3.27 M
|
-81.9
|
0.9
|
$ -0.2
|
 |
 |
SCYNEXIS
SCYX
|
$ 1.01
|
50.4 M
|
$ -72.9 M
|
-2.1
|
19.1
|
$ -0.5
|
 |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 3.12
|
43.9 M
|
$ 1.01 M
|
-14.7
|
1.1
|
$ -0.2
|
 |
 |
Rockwell Medical
RMTI
|
$ 0.94
|
33.8 M
|
$ 1.12 M
|
-22.8
|
0.4
|
$ -0.0
|
 |
 |
TherapeuticsMD
TXMD
|
$ 2.05
|
23.7 M
|
$ -3.18 M
|
-41.4
|
9.0
|
$ -0.0
|
 |
 |
cbdMD
YCBD
|
$ 0.75
|
3.23 M
|
$ -1.22 M
|
-0.2
|
0.2
|
$ -3.9
|
 |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 2.35
|
2.92 M
|
$ -5.22 M
|
-1.0
|
0.2
|
$ -2.2
|
 |
 |
China Pharma Holdings
CPHI
|
$ 0.65
|
2.79 M
|
$ -1.98 M
|
-0.5
|
0.7
|
$ -1.2
|
 |